ClinicalTrials.gov record
Recruiting Phase 3 Interventional

Efficacy and Safety of KAI-9531 Administered Once Weekly Compared With Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

ClinicalTrials.gov ID: NCT07284979

Public ClinicalTrials.gov record NCT07284979. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 6, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Active- and Placebo-Controlled, Partially-Blinded Study to Compare the Efficacy and Safety of KAI-9531 Administered Once Weekly Versus Semaglutide and Placebo in Participants Living With Obesity Who Do Not Have Diabetes

Study identification

NCT ID
NCT07284979
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
Kailera
Industry
Enrollment
1,200 participants

Conditions and interventions

Conditions

Interventions

  • KAI-9531 Drug
  • Placebo Drug
  • Semaglutide Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 29, 2025
Primary completion
Mar 19, 2028
Completion
Apr 16, 2028
Last update posted
Apr 29, 2026

2025 – 2028

United States locations

U.S. sites
25
U.S. states
19
U.S. cities
25
Facility City State ZIP Site status
Kailera Clinical Site Glendale Arizona 85308 Recruiting
Kailera Clinical Site Phoenix Arizona 85012 Recruiting
Kailera Clinical Site Little Rock Arkansas 72205 Recruiting
Kailera Clinical Site Northridge California 91325 Recruiting
Kailera Clinical Site Oceanside California 92058 Recruiting
Kailera Clinical Site Hamden Connecticut 06517 Recruiting
Kailera Clinical Site Stamford Connecticut 06905 Recruiting
Kailera Clinical Site Orange City Florida 32763 Recruiting
Kailera Clinical Site Albany Georgia 31707 Recruiting
Kailera Clinical Site Chicago Illinois 60640 Recruiting
Kailera Clinical Site Newton Kansas 67114 Recruiting
Kailera Clinical Site Shreveport Louisiana 71105 Recruiting
Kailera Clinical Site Farmington Hills Michigan 48334 Recruiting
Kailera Clinical Site Missoula Montana 59804 Recruiting
Kailera Clinical Site Las Vegas Nevada 89148 Recruiting
Kailera Clinical Site Albany New York 12203 Recruiting
Kailera Clinical Site Morehead City North Carolina 28557 Recruiting
Kailera Clinical Site Norman Oklahoma 73069 Recruiting
Kailera Clinical Site East Greenwich Rhode Island 02818 Recruiting
Kailera Clinical Site North Charleston South Carolina 29405 Recruiting
Kailera Clinical Site Spartanburg South Carolina 29303 Recruiting
Kailera Clinical Site Brownsville Texas 78526 Recruiting
Kailera Clinical Site San Antonio Texas 78229 Recruiting
Kailera Clinical Site Manassas Virginia 20110 Recruiting
Kailera Clinical Site Richmond Virginia 23236 Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 7 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07284979, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 29, 2026 · Synced May 6, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07284979 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →